Endpoint definition
↥Filter registries KELA purch., KELA reimb.
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
Extra metadata
Filter registries KELA purch., KELA reimb.
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
Extra metadata
List of similar endpoints to Kela reimbursement Agammaglobulinemia (D80-84) based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
None
All | Female | Male | |
---|---|---|---|
Number of individuals | 137 | 86 | 51 |
Unadjusted prevalence (%) | 0.05 | 0.06 | 0.05 |
Mean age at first event (years) | 43.39 | 45.83 | 39.28 |
Follow-up | Absolute risk | HR [95% CI] | p | N |
---|---|---|---|---|
1998–2019 | - | - | - | - |
15 years | - | - | - | - |
5 years | - | - | - | - |
1 year | - | - | - | - |
Index endpoint: D3_KELA_IMMUDEF – Kela reimbursement Agammaglobulinemia (D80-84)
GWS hits: 0
before Kela reimbursement Agammaglobulinemia (D80-84)
after Kela reimbursement Agammaglobulinemia (D80-84)
Loading survival analyses plot
Loading survival analyses table